CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- 4 Open-market buy Director bought 10,000 shares at $3.74 ($37,400)
- 4 Open-market buy Director bought 1,263 shares at $4.17 ($5,267)
- 4 Open-market buy Director bought 1,576 shares at $3.69 ($5,815)
- 4 Open-market buy Director bought 1,424 shares at an average $3.60 ($5,123)
- 4 Open-market buy Chief Executive Officer bought 2,300 shares at an average $3.52 ($8,106)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 1,700 shares at an average $3.46 ($5,876)
- 4 Open-market buy Director bought 938 shares at $3.49 ($3,274)
- 4 Open-market buy Director bought 3,320 shares at an average $3.32 ($11,023)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,742 shares at an average $3.23 ($18,533)
- 4 Open-market buy Director bought 1,333 shares at $3.64 ($4,852)
- 4 Open-market buy Director bought 8,382 shares at an average $4.02 ($33,684)
- 4 Open-market buy Director bought 1,500 shares at $3.98 ($5,970)
- 4 Open-market buy Director bought 3,582 shares at $4.03 ($14,435)
Page 9 of 13 · 248 filings